Malignant Myeloma in a Patient after Treatment for Osteoporosis with Teriparatide; a Rare Coincidence
Clinical Medicine: Case Reports · 2008
DOI: 10.4137/ccrep.s1026 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Medicine: Case Reports, 2008. Verfasst von Terje Forslund und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Central Finland Health Care District Hospital, Jyväskylä, Finland. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
A breakthrough in understanding of mechanisms of bone structure regulation has brought about the introduction of the new synthetic recombinant human parathyroid hormone 1–34 (PTH1-34; Teriparatide) in the treatment of osteoporosis. These mechanisms, involving the RANKL, RANK, and osteoprotegerin system, are also known to be involved in malignant myeloma (MM) and tumor and bone metastasis development. We report a case in which MM was found after treatment of osteoporosis with teriparatide. We were unable to demonstrate any direct association between the MM and teriparatide treatment. However, it seemed intriguing that similar mechanisms are activated in the development of MM as those being working during teriparatide treatment. In the view of our case, we propose that MM by examination of serum protein fraction should be searched for prior to treatment with teriparatide as it is an exclusion criterion in teriparatide treatment of secondary osteoporosis. A search for other metastatic diseases prior to teriparatide treatment should eventually also be considered. The theoretical basis for our proposal is discussed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, Central Finland Health Care District Hospital, Jyväskylä, Finland.
Zitieren
APA
Forslund, T., Koski, A. M., Koistinen, A., & Sikiö, A. (2008). Malignant Myeloma in a Patient after Treatment for Osteoporosis with Teriparatide; a Rare Coincidence. Clinical Medicine: Case Reports. https://doi.org/10.4137/ccrep.s1026
Vancouver
Forslund T, Koski AM, Koistinen A, Sikiö A. Malignant Myeloma in a Patient after Treatment for Osteoporosis with Teriparatide; a Rare Coincidence. Clinical Medicine: Case Reports. 2008. doi:10.4137/ccrep.s1026
BibTeX
@article{Forslund2008,
author = {Forslund, Terje and Koski, Anna-Mari and Koistinen, Arvo and Sikiö, Anu},
title = {Malignant Myeloma in a Patient after Treatment for Osteoporosis with Teriparatide; a Rare Coincidence},
journal = {Clinical Medicine: Case Reports},
year = {2008},
doi = {10.4137/ccrep.s1026}
}
EUVIMED